본문 바로가기
KERD
논문KCI 등재

Primary pyomyositis in North India: a clinical, microbiological, and outcome study

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류내과학

초록

Background/Aims: Pyomyositis is an infective condition with primary involvement of the skeletal muscles. There is sparse recent literature on patients with pyomyositis. Methods: This study was carried out at emergency services of a tertiary care center located in subtropical area of Indian subcontinent. Results: Sixty-two patients of primary pyomyositis formed the study cohort. Mean age of occurrence was 29.9 ± 14.8 years. There were 54 men. Twelve patients had underlying medical diseases. Muscle pain was seen in all 62 patients. Forty-eight patients (77.4%) had the fever. Most common site of involvement was thigh muscles (n = 29, 46.8%). Forty-nine patients (79%) presented in the suppurative stage of illness. Patients with comorbidities were older (age: median 36 years [interquartile range (IQR), 25 to 47] vs. 24 years [IQR, 16 to 35], p = 0.024), had higher culture positivity with gram-negative organisms (8/9 [88.89%] vs. 6/29 [20.69%], p = 0.001). Importantly, higher number of these patients received inappropriate antibiotics initially. Patients with positive pus culture result had higher complication rate (32/38 [84.21%] vs. 10/18 [55.56%], p = 0.044). Six patients (9.7%) had in-hospital mortality. Lower first-day serum albumin, initial inappropriate antibiotic therapy, and advanced form of the disease at presentation were associated with increased in-hospital mortality. Conclusions: Primary pyomyositis is not an uncommon disease entity. Patients with comorbidities were more likely to receive initial inappropriate antibiotic therapy. Patients with positive pus culture report had the higher rate of complications. Lower first-day serum albumin, initial inappropriate antibiotic therapy and advanced form of the disease at presentation were associated with increased in-hospital mortality.

Abstract

Background/Aims: Pyomyositis is an infective condition with primary involvement of the skeletal muscles. There is sparse recent literature on patients with pyomyositis. Methods: This study was carried out at emergency services of a tertiary care center located in subtropical area of Indian subcontinent. Results: Sixty-two patients of primary pyomyositis formed the study cohort. Mean age of occurrence was 29.9 ± 14.8 years. There were 54 men. Twelve patients had underlying medical diseases. Muscle pain was seen in all 62 patients. Forty-eight patients (77.4%) had the fever. Most common site of involvement was thigh muscles (n = 29, 46.8%). Forty-nine patients (79%) presented in the suppurative stage of illness. Patients with comorbidities were older (age: median 36 years [interquartile range (IQR), 25 to 47] vs. 24 years [IQR, 16 to 35], p = 0.024), had higher culture positivity with gram-negative organisms (8/9 [88.89%] vs. 6/29 [20.69%], p = 0.001). Importantly, higher number of these patients received inappropriate antibiotics initially. Patients with positive pus culture result had higher complication rate (32/38 [84.21%] vs. 10/18 [55.56%], p = 0.044). Six patients (9.7%) had in-hospital mortality. Lower first-day serum albumin, initial inappropriate antibiotic therapy, and advanced form of the disease at presentation were associated with increased in-hospital mortality. Conclusions: Primary pyomyositis is not an uncommon disease entity. Patients with comorbidities were more likely to receive initial inappropriate antibiotic therapy. Patients with positive pus culture report had the higher rate of complications. Lower first-day serum albumin, initial inappropriate antibiotic therapy and advanced form of the disease at presentation were associated with increased in-hospital mortality.

참고문헌 (34)

  1. Bickels J, "Primary pyomyositis", J Bone Joint Surg Am, 84-A, pp.2277~2286 (2002)
  2. Chauhan S, "Tropical pyomyositis (myositis tropicans): current perspective", Postgrad Med J, 80, pp.267~270 (2004)[DOI]
  3. Agarwal V, "Pyomyositis", Neuroimaging Clin N Am, 21, pp.975~983 (2011)[DOI]
  4. Malhotra P, "Tropical pyomyositis: experience of a tertiary care hospital in north-west India", J Assoc Physicians India, 48, pp.1057~1059 (2000)
  5. Sharma A, "Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India", Clin Rheumatol, 29, pp.45~51 (2010)[DOI]
  6. Chiedozi LC, "Pyomyositis: review of 205 cases in 112 patients", Am J Surg, 137, pp.255~259 (1979)[DOI]
  7. Gambhir IS, "Tropical pyomyositis in India: a clinico-histopathological study", J Trop Med Hyg, 95, pp.42~46 (1992)
  8. Chattopadhyay B, "Tropical pyomyositis", N Am J Med Sci, 5, pp.600~603 (2013)[DOI]
  9. Martinez-de Jesus FR, "Clinical stage, age and treatment in tropical pyomyositis: a retrospective study including forty cases", Arch Med Res, 27, pp.165~170 (1996)
  10. Crum NF, "Bacterial pyomyositis in the United States", Am J Med, 117, pp.420~428 (2004)[DOI]
  11. Hall RL, "Pyomyositis in a temperate climate: presentation, diagnosis, and treatment", J Bone Joint Surg Am, 72, pp.1240~1244 (1990)[DOI]
  12. Unnikrishnan PN, "Tropical primary pyomyositis in children of the UK: an emerging medical challenge", Int Orthop, 34, pp.109~113 (2010)[DOI]
  13. Block AA, "Staphylococcal pyomyositis in a temperate region: epidemiology and modern management", Med J Aust, 189, pp.323~325 (2008)
  14. Levy MM, "2001 SCCM", ESKEY ICM, ATS, pp.SIS international sepsis definitions conference, Crit Care Med[DOI]
  15. Chiu SK, "Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis", J Microbiol Immunol Infect, 41, pp.286~293 (2008)
  16. Markanday A, "Acute phase reactants in infections: evidence- based review and a guide for clinicians", Open Forum Infect Dis, 2, pp.ofv098~ (2015)[DOI]
  17. Don BR, "Serum albumin: relationship to inflammation and nutrition", Semin Dial, 17, pp.432~437 (2004)[DOI]
  18. Nicholson JP, "The role of albumin in critical illness", Br J Anaesth, 85, pp.599~610 (2000)[DOI]
  19. Fleck A, "Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury", Lancet, 1, pp.781~784 (1985)
  20. Jevons MP, ""Celbenin": resistant staphylococci", Brit Med J, 1, pp.124~125 (1961)
  21. Saravolatz LD, "Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak", Ann Intern Med, 96, pp.11~16 (1982)[DOI]
  22. Herold BC, "Community- acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk", JAMA, 279, pp.593~598 (1998)[DOI]
  23. Popovich KJ, "Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?", Clin Infect Dis, 46, pp.787~794 (2008)[DOI]
  24. Saiman L, "Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women", Clin Infect Dis, 37, pp.1313~1319 (2003)[DOI]
  25. Huang H, "Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California", J Clin Microbiol, 44, pp.2423~2427 (2006)[DOI]
  26. Zalavras CG, "Increased oxacillin resistance in thigh pyomyositis in diabetic patients", Clin Orthop Relat Res, 466, pp.1405~1409 (2008)[DOI]
  27. Melzer M, "Is methicillin- resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia", Clin Infect Dis, 37, pp.1453~1460 (2003)[DOI]
  28. Wolkewitz M, "Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge", J Antimicrob Chemother, 66, pp.381~386 (2011)[DOI]
  29. Chen SY, "Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia", Medicine (Baltimore), 89, pp.285~294 (2010)[DOI]
  30. Cosgrove SE, "Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis", Clin Infect Dis, 36, pp.53~59 (2003)[DOI]
  31. Vigil KJ, "Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies", Clin Infect Dis, 50, pp.374~380 (2010)[DOI]
  32. Chiu NC, "Clinical characteristics of pyomyositis in children: 20-year experience in a medical center in Taiwan", J Microbiol Immunol Infect, 42, pp.494~499 (2009)
  33. Goldwasser P, "Association of serum albumin and mortality risk", J Clin Epidemiol, 50, pp.693~703 (1997)[DOI]
  34. Vincent JL, "Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials", Ann Surg, 237, pp.319~334 (2003)

관련 논문AI추천

이 간행물의 다른 논문 (27건)